Colorectal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Recently it has been reported that expression of newly characterized human genes, UBE2Q1 and UBE2Q2, putative members of ubiquitin-conjugating enzyme family (E2), has been also changed in colorectal cancer.
|
26745068 |
2015 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Recently it has been reported that expression of newly characterized human genes, UBE2Q1 and UBE2Q2, putative members of ubiquitin-conjugating enzyme family (E2), has been also changed in colorectal cancer.
|
26745068 |
2015 |
Acute lymphocytic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data suggest that the newly characterized human gene, UBE2Q2, may have implications for the pathogenesis of ALL and could be used for molecular diagnosis purposes in the future.
|
22642244 |
2012 |
Childhood Acute Lymphoblastic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data suggest that the newly characterized human gene, UBE2Q2, may have implications for the pathogenesis of ALL and could be used for molecular diagnosis purposes in the future.
|
22642244 |
2012 |
Adult Acute Lymphocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data suggest that the newly characterized human gene, UBE2Q2, may have implications for the pathogenesis of ALL and could be used for molecular diagnosis purposes in the future.
|
22642244 |
2012 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In this study, we found high expression levels of UBE2Q2 in human head and neck carcinoma cell lines and cancer tissues by using an anti-UBE2Q2 antibody at the protein level.
|
19723876 |
2009 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
However, the involvement of UBE2Q2 in carcinogenesis has not been fully elucidated.
|
19723876 |
2009 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In this study, we found high expression levels of UBE2Q2 in human head and neck carcinoma cell lines and cancer tissues by using an anti-UBE2Q2 antibody at the protein level.
|
19723876 |
2009 |
Recurrent Head and Neck Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer.
|
19723876 |
2009 |
Hypopharyngeal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
UBE2Q2, also designated Ubci, is one of the ubiquitin-conjugating enzymes (E2), and it has been reported that mRNA of UBE2Q2 is highly expressed in human head and neck squamous cell carcinoma, particularly hypopharyngeal carcinoma.
|
19723876 |
2009 |
Head and Neck Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we found high expression levels of UBE2Q2 in human head and neck carcinoma cell lines and cancer tissues by using an anti-UBE2Q2 antibody at the protein level.
|
19723876 |
2009 |
Malignant neoplasm of breast
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
It has been previously reported that the newly characterized human gene UBE2Q2, a putative member of the ubiquitin-conjugating enzyme family, is over-expressed in the tumor mass and invasive epithelium in head and neck squamous cell carcinoma and breast cancer.
|
22642244 |
2012 |
Breast Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
It has been previously reported that the newly characterized human gene UBE2Q2, a putative member of the ubiquitin-conjugating enzyme family, is over-expressed in the tumor mass and invasive epithelium in head and neck squamous cell carcinoma and breast cancer.
|
22642244 |
2012 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our data suggest that the novel human gene UBE2Q2 may have implications for pathogenesis of breast cancer and could be used in molecular diagnosis purposes in the future.
|
20193842 |
2010 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our data suggest that the novel human gene UBE2Q2 may have implications for pathogenesis of breast cancer and could be used in molecular diagnosis purposes in the future.
|
20193842 |
2010 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
It has been previously reported that the newly characterized human gene UBE2Q2, a putative member of the ubiquitin-conjugating enzyme family, is over-expressed in the tumor mass and invasive epithelium in head and neck squamous cell carcinoma and breast cancer.
|
22642244 |
2012 |
Squamous cell carcinoma of the head and neck
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
It has been previously reported that the newly characterized human gene UBE2Q2, a putative member of the ubiquitin-conjugating enzyme family, is over-expressed in the tumor mass and invasive epithelium in head and neck squamous cell carcinoma and breast cancer.
|
22642244 |
2012 |
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
We have previously reported that the novel human gene, UBE2Q2, is a putative ubiquitin-conjugating enzyme that is located on chromosome 15 and is overexpressed in tumor mass and invasive epithelium in head and neck squamous-cell carcinoma.
|
20193842 |
2010 |
Squamous cell carcinoma of the head and neck
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We have previously reported that the novel human gene, UBE2Q2, is a putative ubiquitin-conjugating enzyme that is located on chromosome 15 and is overexpressed in tumor mass and invasive epithelium in head and neck squamous-cell carcinoma.
|
20193842 |
2010 |
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
These findings suggest that UBE2Q2 is a novel oncosuppressor that inhibits tumor growth and is related to the resistance to anticarcinoma agents and that UBE2Q2 likely functions as a novel diagnostic tool and a potentially therapeutic target for head and neck squamous cell carcinoma.
|
19723876 |
2009 |
Squamous cell carcinoma of the head and neck
|
0.030 |
Biomarker
|
disease |
BEFREE |
These findings suggest that UBE2Q2 is a novel oncosuppressor that inhibits tumor growth and is related to the resistance to anticarcinoma agents and that UBE2Q2 likely functions as a novel diagnostic tool and a potentially therapeutic target for head and neck squamous cell carcinoma.
|
19723876 |
2009 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.
|
31451708 |
2019 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.
|
31451708 |
2019 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.
|
31451708 |
2019 |
Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |